We Don't Discover Cures, We Help YOU Engineer Them
AI-powered precision medicine platform that transforms genomic data into actionable therapeutic intelligence.
Trusted By Leading Organizations
CrisPRO.ai builds trust through transparency and auditability. World-class research institutions and technology leaders trust us to accelerate breakthrough discoveries with honest limitations and evidence-backed recommendations.

American Association for Cancer Research
Leading cancer research organization advancing the prevention and cure of cancer
Visit Website
UC Berkeley
Premier public research university driving innovation in biotechnology and genomics
Visit Website
American Association for Cancer Research
Leading cancer research organization advancing the prevention and cure of cancer
Visit WebsiteInterested in partnering with CrisPRO.ai?
Partner With UsYou Bring the Science, We Bring the AI Engineering
Validated in-silico predictions for variant impact, drug fit, and CRISPR design.
Our Capabilities
Comprehensive in-silico tools for research oncology, from variant analysis to therapeutic guidance
Will It Work For Me?
Clinical Decision Support
Universal Hypothesis Testing
Research Acceleration
Design Precision Interventions
Therapeutic Design
Multi-Modal AI Validation
Platform Intelligence
Ask Questions Naturally
Conversational AI
Production-Ready SaaS
Enterprise Platform
From 90% Failure to Predictable Success
Transform your drug development pipeline from gambling to engineering with our 3-stage in-silico platform. Every stage includes SAE explainability—see exactly what the AI is thinking.👇 Scroll down to try each stage live with interactive demos.
Stage 1: Target Identification & Validation
From months of exploration to 60-second conquest
Mathematical proof of functional disruption + Achilles' heel confirmation
Stage 2: Lead Discovery & Optimization
We don't discover leads; we engineer them
First-principles design with embedded optimization
Stage 3: Pre-Clinical Confirmation
From expensive wet-lab to near-zero-cost in-silico trial
Cellular-level simulation + structural proof of mechanism
Discovery vs. Engineering
The fundamental shift from a game of chance to a discipline of creation.
The Old Way: A Funnel
Low-probability screening
Millions of Molecules
Searching...
The New Doctrine: A Factory
High-certainty generation
🧠 SAE Explainability
ExploreAI Engineering
Engineering...
Validated & Patent-Ready
The Transformation
We've replaced the needle-in-haystack approach with precision engineering. Every therapeutic candidate is designed for success, not discovered by chance.
🧬 Research
Try it live: Experience the complete drug development pipeline powered by AI. Select a stage above to run an interactive demo with real variants and see SAE explainability in action.
Target Validation
Hereditary Breast Cancer Triage
Ready to Build Your Next Cancer Drug?
This demonstration will show you how to go from a genetic variant to a validated therapeutic target using our complete AI-powered drug development pipeline.
Research Use Only - Simulated Results
Calculate Your R&D ROI Improvement
See exactly how CrisPRO's AI reduces failure costs and accelerates your pipeline.Real ROI calculations for biotech executives.
Calculate Your R&D ROI Improvement
See exactly how CrisPRO's AI reduces failure costs and accelerates your pipeline
🚀 Watch live simulation with industry data
Live ROI Simulation
CrisPRO Target Analysis
Target Validation Score
+18,420
VALIDATED TARGET
Oracle AI validating therapeutic target in real-time
CrisPRO ROI Impact
Wasted on failed targets (85% failure rate)
Saved by reducing target validation failures
vs 15% current (+0% improvement)
18 months → 1 week with Oracle AI
Return on CrisPRO investment ($2M/year)
What This Means for Your Pipeline:
Ready to Transform Your Numbers?
Schedule a demo to see how these savings apply to your specific programs
